Connect with us

Current Affairs

Here is Zimbabwe’s Breakthrough in HIV Prevention with Lenacapavir Rollout

Published

on

Here is Zimbabwe’s Breakthrough in HIV Prevention with Lenacapavir Rollout
Image Credit: https://x.com/USEmbZim/status/1970407837948932296/photo/1

Zimbabwe is making history as one of only ten countries worldwide selected to roll out lenacapavir, a revolutionary twice-yearly HIV prevention medicine.

Announced by the U.S. Embassy in Harare, this groundbreaking initiative, in partnership with Gilead Sciences and the Global Fund, marks a pivotal moment in the global fight against HIV/AIDS.

With a clinical trial success rate exceeding 99%, lenacapavir offers hope for millions and positions Zimbabwe as a leader in ending new HIV infections.

A New Era in HIV Prevention: Lenacapavir’s Global Impact

Lenacapavir, developed by U.S.-based Gilead Sciences, is the world’s first twice-yearly injectable HIV prevention medicine.

Unlike daily oral medications, this long-acting treatment offers a convenient and highly effective solution to prevent HIV infection.

In large-scale clinical trials, over 99% of participants using lenacapavir remained HIV-negative, showcasing its potential to transform HIV prevention strategies worldwide.

For Zimbabwe, being selected as one of the first countries to roll out this medicine is a testament to its commitment to combating the HIV epidemic.

Why Zimbabwe’s Selection Matters

Zimbabwe has been a frontline fighter in the battle against HIV/AIDS for decades. With a population heavily impacted by the epidemic, the introduction of lenacapavir represents a game-changer.

The U.S. Embassy in Harare, in collaboration with Gilead Sciences and the Global Fund, is spearheading this initiative to ensure that Zimbabweans, particularly vulnerable groups like pregnant and breastfeeding women, gain access to this life-saving medicine.

This rollout not only aims to reduce new infections but also strengthens Zimbabwe’s healthcare infrastructure, paving the way for a healthier future.

Key Benefits of Lenacapavir in Zimbabwe

The lenacapavir rollout in Zimbabwe is more than just a medical advancement—it’s a holistic approach to public health. Here are the key benefits:

– Protecting Future Generations: By prioritising pregnant and breastfeeding women, lenacapavir helps prevent mother-to-child HIV transmission, safeguarding Zimbabwe’s next generation.

– Strengthening Healthcare Systems: The partnership with the Global Fund and Gilead Sciences empowers Zimbabwe’s healthcare systems to deliver innovative treatments effectively.

– Affordability and Accessibility: Efforts are underway to make lenacapavir affordable and widely available, ensuring no one is left behind in the fight against HIV.

– High Efficacy: With a 99% success rate in preventing HIV, lenacapavir offers unmatched protection compared to existing prevention methods.

A Global Partnership for a Healthier Future

The success of this initiative is rooted in international collaboration. The U.S. Embassy Harare, through its partnership with Gilead Sciences and the Global Fund, exemplifies American leadership in global health innovation.

This collaboration not only brings cutting-edge medicine to Zimbabwe but also sets a model for other nations.

By combining resources, expertise, and commitment, this partnership is driving progress toward a world free of new HIV infections.

How Lenacapavir Works

Lenacapavir is a long-acting injectable administered every six months, making it a convenient alternative to daily HIV prevention pills.

It works by inhibiting the HIV at multiple stages of its lifecycle, offering robust protection against infection.

This breakthrough is particularly significant for high-risk groups, such as young women and key populations in Zimbabwe, where HIV prevalence remains a challenge. The twice-yearly dosing schedule reduces the burden of adherence, making it easier for individuals to stay protected.

The Broader Impact on Zimbabwe’s Fight Against HIV

Zimbabwe’s selection for the lenacapavir rollout is a major step toward achieving the global goal of ending HIV as a public health threat by 2030. By focusing on prevention, this initiative complements existing efforts like antiretroviral therapy (ART) and community-based HIV education programs.

Furthermore, it empowers Zimbabwe to lead its own response to the epidemic, fostering resilience and self-reliance in its healthcare system.

 A Vision for a Healthier Zimbabwe

The introduction of lenacapavir is more than a medical milestone—it’s a vision for a safer, stronger, and healthier Zimbabwe.

By reducing new HIV infections, protecting vulnerable populations, and strengthening healthcare systems, this initiative lays the foundation for a future where communities thrive free from the burden of HIV/AIDS.

The U.S. Embassy in Harare’s commitment to this cause reflects a shared global vision of health equity and innovation.

How Zimbabwe’s Success Can Inspire the World

Zimbabwe’s role in the lenacapavir rollout serves as an inspiration for other nations battling HIV/AIDS.

The country’s proactive approach, supported by international partners, demonstrates how innovation, collaboration, and accessibility can transform public health outcomes. As Zimbabwe leads the way, it sets a precedent for other countries to adopt similar strategies, bringing the world closer to ending the HIV epidemic.

Zimbabwe’s selection as one of the first countries to roll out lenacapavir is a historic milestone in the global fight against HIV.

With a 99% efficacy rate, this twice-yearly injectable medicine has the potential to save millions of lives and reshape the future of HIV prevention.

Through partnerships with the U.S. Embassy in Harare, Gilead Sciences, and the Global Fund, Zimbabwe is not only protecting its citizens but also leading the charge toward a world without new HIV infections.

This initiative is a powerful reminder that with innovation, collaboration, and commitment, we are not just fighting HIV—we are winning.

Current Affairs

Minister Rwodzi Charts Path as Sector Takes Lead in GDP Growth

Published

on

Itai Mazire

Tourism and Hospitality Industry Minister Barbara Rwodzi has implored players in the sector to embrace innovation, sustainability, and stronger partnerships to safeguard Zimbabwe’s tourism gains, as the industry now leads national GDP growth ahead of mining and agriculture.

In a speech delivered on her behalf by Tourism Permanent Secretary Dr. Takaruza Munyanyiwa at the Hospitality Association of Zimbabwe (HAZ) Summit and Annual General Meeting in Harare today, Minister Rwodzi said the country stood at a “historic crossroads” following its recent listing by Forbes as the best destination to visit in 2025.

“This is a well-deserved accolade which we should celebrate and sustain going forward. Congratulations, makorokoto, amhlope to the service providers of the tourism and hospitality industry of Zimbabwe.”

The Minister applauded the sector’s resilience in the face of pandemics, economic headwinds, and climate-related shocks, noting that the spirit of Zimbabwean hospitality remains unbroken.

“We have continued to smile, to serve, and to tell our authentic story, hence reaping the rewards now,” she said.

Giving an update on performance, Minister Rwodzi reported that international tourist arrivals grew by 9 percent between January and September 2025 compared to the same period last year, with strong traffic from the Americas, Africa, and Asia.

Domestic travel also surged by 20.9 percent over the same period, while the sector generated approximately USD 922 million in 2025 a 10 percent rise from the USD 839 million recorded last year.

“These are encouraging signs that our recovery is gaining positive traction. But future-proofing requires more than recovery it demands transformation,” she said.

Minister Rwodzi outlined five pillars she said would anchor the transformation of the sector: digitalisation; sustainable and climate-resilient tourism; human capital development; infrastructure and connectivity; and stronger branding and market diversification.

“The future of hospitality is digital,” she said. “We must move from brochures to big data, from paper-based booking to smart platforms.”

She urged operators to embrace online booking systems, virtual reality tourism aids, and other digital tools that enhance visitor experiences.

On sustainability, Minister Rwodzi said protecting Zimbabwe’s natural and cultural heritage was “not an expense it is an investment in the longevity of our industry.”

The Minister stressed the need to invest in human capital, calling on operators to work closely with academia to bridge skills gaps and develop tomorrow’s hospitality innovators. She highlighted the First Lady, Dr. Auxillia Mnangagwa’s gastronomy vision as a key avenue for elevating Zimbabwe’s culinary offerings.

On infrastructural development across the country, she said it remained central to competitiveness: “A tourist’s journey begins long before they reach our front desk — it begins on a road, a runway, or a mobile network.”

Minister Rwodzi reiterated that Government is committed to creating an enabling environment, pointing to the recent reduction of tourism fees by up to 50 percent to lower operating costs.

“Future-proofing cannot be achieved by Government alone,” she said. “The private sector is the engine of creativity, investment, and service excellence.”

Her call for collaboration was anchored on an African proverb which states that, “Tomorrow belongs to the people who prepare for it today.”

The Minister said the role of HAZ remained critical as Zimbabwe eyes increased international tourist inflows.

“The world’s eyes are turning towards Zimbabwe. We have the assets, we have the people, we have the passion so why not?” she said.

“To HAZ, your role has never been more critical. You are the unified voice of the hospitality industry. Your strength lies in your collective action.”

She said the ongoing summit provided a platform to “strategise, innovate, and build consensus” as the sector pushes towards Vision 2030.

“The potential is vast. The time is now. Let us build not just an industry, but a legacy,” said Minister Rwodzi.

Continue Reading

Current Affairs

Apostolic Church Founder Paul Mwazha Dies at 107

Published

on

Zimbabwe and the wider African Christian community are mourning the loss of Bishop Paul Mwazha, the revered founder of the Apostolic Church in Africa, who passed away today at the remarkable age of 107.

Bishop Mwazha, widely regarded as one of the continent’s most influential religious leaders, dedicated his life to the growth and spiritual guidance of his church, which boasts millions of followers across Zimbabwe and beyond. His teachings, rooted in faith, discipline, and community service, have left an enduring legacy that continues to shape generations.

The Apostolic Church in Africa under his leadership became a cornerstone of spiritual life in many communities, providing not only religious guidance but also social support and education initiatives. Church leaders have called for prayers as they prepare for national and regional mourning rituals.

Further details on funeral arrangements and memorial services are expected to be released in the coming days.

Continue Reading

Business

Zimbabwe Bets Big on Biotech to Fuel Industrial Revolution

Published

on

By

Dr. Eng. Willie Ganda

 

By Enia Dube

The Minister of Higher and Tertiary Education, Innovation, Science and Technology Development, Hon. Dr Fredrick Shava, has thrown his weight behind biotechnology as a key driver of the country’s industrialisation and modernisation agenda.

Speaking at the National Biotechnology Authority (NBA) Strategic Planning Workshop in Kadoma, Dr Shava urged the Authority to identify biotechnology-led opportunities that can boost national production and accelerate economic growth.

“Biotechnology serves as a key catalyst for NDS2 implementation, advancing inclusive economic growth, job creation, and sustainable industrial development,” Dr Shava said, emphasising the need to integrate biotechnology into national value chains to unlock a biotechnology-driven economy. He added that this would turn innovation into industry, knowledge into enterprise, and science into jobs.

The NBA has made notable progress in establishing a strong regulatory framework, promoting biotechnology research and commercialisation, and raising public awareness about the sector’s potential. The Authority has successfully commercialised products such as Mapfura wine and Cofsol cough syrup, and has several other biotechnology products in the pipeline.

Incoming NBA Board Chairperson, Professor Idah Sithole-Niang, echoed Dr Shava’s sentiments, emphasising that the Authority’s five-year strategic plan must meaningfully contribute to the attainment of Vision 2030. “This event marks a significant milestone in the Authority’s ongoing efforts to enhance the role of biotechnology in Zimbabwe’s socio-economic development,” she said.

The workshop aimed to realign priorities and resources in response to emerging technologies and global biotechnology trends, and develop a strategic roadmap to strengthen biotechnology as a key driver of Zimbabwe’s socio-economic transformation. The rapidly evolving global biotechnology landscape, including advancements in gene editing, bio-manufacturing, and climate-smart innovations, presents both new opportunities and challenges for Zimbabwe.

“We recognise the pressing need for an inclusive and forward-looking strategic plan that can navigate the complexities of the biotechnology landscape,” Professor Sithole-Niang noted. The workshop was attended by researchers, government officials, and NBA staff, who are optimistic about the potential of biotechnology to drive Zimbabwe’s economic transformation and achieve Vision 2030.

Continue Reading

Trending